PD-MIND
Parkinson disease with mild cognition impairment treated with nicotinic agonist drug
- Started
- 2019-05-01
- Website
- https://www.pd-mind.org/
Parkinson disease with mild cognition impairment treated with nicotinic agonist drug
PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease
Inflammation and AD: modulating microglia function - focussing on TREM2 and CD33
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
Psychiatric ratings using intermediate stratified markers 2
Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
Remote assessment of disease and relapse – Alzheimer’s disease
Remote Assessment of Disease and Relapse in Central Nervous System Disorders